Live Breaking News & Updates on Therapeutic Area Lead

Stay updated with breaking news from Therapeutic area lead. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Progressing personalised cell therapies in oncology

This article discusses the current landscape of CAR T therapies and highlights the potential of a novel BCMA-targeted oncology treatment. ....

United States , Imran Khan , American Cancer Society , Albert Einstein College Of Medicine , Oncology Us Medical Affairs , Rutgers New Jersey Medical School , Drug Administration , National Cancer Institute , Rutgers Cancer Institute Of New Jersey , Vice President , Medical Affairs , Johnson Innovative Medicine , Vice President Medical Affairs , Johnson Innovative , Medical Science Liaison , Therapeutic Area Lead , Albert Einstein College , Clinical Assistant Professor , Rutgers Cancer Institute , New Jersey , Robert Wood Johnson Medical , Engineering Immune Cells , Treat Cancer , National Cancer , T Cell Therapy ,

Janssen-Cilag seeks European approval for guselkumab in ulcerative colitis and Crohn's disease treatment

Janssen-Cilag International NV, a Johnson & Johnson company, today announced it has submitted applications to the European Medicines Agency (EMA) seeking to expand the Marketing Authorization Application for TREMFYA® (guselkumab) to include the treatment of adult patients with moderately to severely active ulcerative colitis and moderately to severely active Crohn’s disease. ....

David Lee , European Medicines Agency , Drug Administration , European Union , Janssen Cilag International , Marketing Authorization Application , Ludovic De Beaucoudrey , Senior Director , Therapeutic Area Lead , Janssen Cilag Limited , Global Therapeutic Area Head Immunology , Johnson Innovative , Disease Week Annual Meeting , United European Gastroenterology Week , Biologics License Application , Crohns Disease , Ulcerative Colitis ,

Johnson & Johnson submits regulatory applications to

Media contact:Sophie DaneauSdaneau@its.jnj.com+33 6 3178 8798Investor contact:Raychel Kruperinvestor-relations@its.jnj.com For European and UK. ....

United Kingdom , Region Flamande , David Lee , Sophie Daneau , Drug Administration , Japan Pharmaceuticals , Exchange Commission , European Union , Canadian Agency For Drugs Technologies In Health , Janssen Biotech Inc , Crohn Colitis Foundation , None Of Janssen Research Development , Devices Agency , Janssen Research Development , European Medicines Agency , Janssen Cilag International , Marketing Authorisation Application , Ludovic De Beaucoudrey , Senior Director , Therapeutic Area Lead , Janssen Cilag Limited , Global Therapeutic Area Head Immunology , Johnson Innovative , Disease Week Annual Meeting , United European Gastroenterology Week , Biologics License Application ,

Charles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024

Researchers highlight translational services to optimize drug development programs

. ....

United States , San Diego , San Diego Convention Center , United Kingdom , Charles River , Julia Schueler , Isabelle Caffry , Kolin Hribar , Aidan Synnott , Cypre Inc , Charles River Laboratories International Inc , Preclinical Research In Vivo , American Association For Cancer Research , Corporate Development , Global Discovery Services , Charles River Laboratories International , American Association , Cancer Research , River Launches New Tools , Support Oncology Research , Price Estimator , Cancer Model Database , Greater Boston , Predictive Tumor Models , Digital Twins , Therapeutic Area Lead ,

Mental health – from research to remission

Mental health – from research to remission
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

Tamara Werner Kiechle , European Year Of Mental Health , European Commission , European Union , European Economic , Social Committee , European Year , Mental Health , Therapeutic Area Lead , Pulmonary Hypertension ,